August 29, 2014 10:04 AM ET

Pharmaceuticals

Company Overview of Imarx Therapeutics, Inc.

Company Overview

As of May 14, 2010, Imarx Therapeutics, Inc. was acquired by Sycamore Films, Inc., in a reverse merger transaction. Previously, the company focused on the research, development, and commercialization of therapies for stroke and other vascular disorders using its microbubble technology. Its lead program, SonoLysis, involves the administration of its MRX-801 microspheres and ultrasound to break up blood clots and restore blood flow to oxygen deprived tissues. The company was founded in 1999 and is based in Redmond, Washington.

12277 134th NE

Suite 202

Redmond, WA 98052

United States

Founded in 1999

Phone:

425-821-5501

Fax:

425-821-1404

Key Executives for Imarx Therapeutics, Inc.

Imarx Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Scion Pharmaceuticals, Inc. United States
Equon Pharmaceuticals, Inc. United States
Alba Therapeutics Corporation United States
GlaxoSmithKline Consumer Healthcare, L.P. United States
Aeglea BioTherapeutics Holdings, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Imarx Therapeutics, Inc., please visit www.imarx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.